Background The role of ivermectin in the treatment of COVID-19 is still under debate, yet the
drug has been widely used in some parts of the world, as shown by impressive market data …

Background: During the coronavirus disease (COVID)-19 pandemic several drugs were
used to manage the patients mainly those with a severe phenotype. Potential drugs were …

Long-term sequelae of coronavirus disease (COVID)-19 are frequent and of major concern.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the host …

This study tracked five pharmaceutically active compounds (PhACs) in Mexico City's
sewage, namely, famotidine, indomethacin, dexamethasone, azithromycin, and ivermectin …

Abstract Until January 2023, Brazil recorded 37 million COVID-19 cases despite the
decrease in mortality due to mass vaccination efforts against COVID-19. The infection …

This paper examines the populational impact of the COVID-19 vaccinations for Brazil.
Therefore, our analysis takes into account the time series of the daily number of deaths …

Since the onset of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic, various therapeutic agents have been repurposed to treat patients with …

Background Clinical benefit of molnupiravir (MPV) in coronavirus disease 2019 (COVID-19)–
infected subpopulations is unclear. Methods We used a matched cohort study design to …

Previous coronavirus epidemics were associated with increased maternal morbidity,
mortality, and adverse obstetric outcomes. Reports for SARS-CoV-2 indicate that the …

Brazil was one of the countries most impacted by the COVID-19 pandemic, with a cumulative
total of nearly 700,000 deaths by early 2023. The country's federative units were unevenly …